08045478006
info@ygiispharma.com
idarubicin injection

idarubicin injection

11 USD ($)/Piece

Product Details:

  • Indication Acute myeloid leukemia (AML), relapsed or refractory cases, and other hematologic malignancies as per clinical protocol.
  • Dosage Form Injection
  • Salt Composition Idarubicin (as hydrochloride)
  • Enzyme Types Not applicable (Cytotoxic antibiotic)
  • Feature Sterile, single-use vial, ready-to-administer
  • Ingredients Idarubicin hydrochloride, excipients, sterile water for injection
  • Application Hospital and institutional use. Administered intravenously under healthcare supervision.
  • Click to View more
X

idarubicin injection Price And Quantity

  • 5 Piece
  • 1.10 - 11.00 USD ($)/Piece
  • 11 USD ($)/Piece

idarubicin injection Product Specifications

  • Hospital and institutional use. Administered intravenously under healthcare supervision.
  • Not applicable (Cytotoxic antibiotic)
  • 3.0 4.0
  • Acute myeloid leukemia (AML), relapsed or refractory cases, and other hematologic malignancies as per clinical protocol.
  • Sterile, single-use vial, ready-to-administer
  • Idarubicin hydrochloride, excipients, sterile water for injection
  • 24 months (unopened vial)
  • Clear red-orange solution
  • Injection
  • Store below 25C. Protect from light, do not freeze.
  • Odorless (solution for injection)
  • Idarubicin (as hydrochloride)
  • WHO/US FDA/EMA compliant (if applicable by supplier)
  • Prescription Only (Rx)
  • Compatible with 0.9% saline or 5% dextrose for infusion
  • No reconstitution required for ready-to-use presentations
  • 5 mg/5 mL, 10 mg/10 mL, or as per manufacturer specification
  • Dispose of as hazardous pharmaceutical waste according to local guidelines
  • Intravenous (IV) infusion or bolus
  • Individually packed vials in secondary box packaging
  • Glass vial with rubber stopper and aluminum seal
  • Handle with cytotoxic precautions; use gloves and protective equipment

idarubicin injection Trade Information

  • mumbai or DHL
  • Western Union, Paypal, Cash Advance (CA)
  • 10 Piece Per Day
  • 5 Days
  • Contact us for information regarding our sample policy
  • Australia, South America, Eastern Europe, Western Europe, Middle East, Central America, Asia, North America, Africa
  • All India

Product Description

Idarubicin is used treat acute myelogenous leukemia (AML; a type of cancer of the white blood cells) in combination with other medications. Idarubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.15-Dec-2012

Ready-to-Use Sterile Formulation

Idarubicin injection is conveniently available in a ready-to-administer form, eliminating the need for reconstitution. This streamlines pharmacy workflows, enhances patient safety, and reduces preparation errors. The product is supplied in a sterile, clear red-orange solution contained within glass vials, specially sealed to maintain integrity.


Strict Compliance and Safe Handling

Manufactured to meet international standards-including WHO, US FDA, or EMA guidelines when applicable-the injection must be handled with full cytotoxic precautions. All personnel should use gloves and protective gear during preparation and administration, and all waste should be disposed of according to hazardous pharmaceutical protocols.


Optimal Storage and Shelf Life

For maximum efficacy and safety, idarubicin injection should be stored below 25C, protected from light, and never frozen. Each vial remains stable for up to 24 months unopened. Secondary box packaging ensures safe transportation and storage until use in clinical settings.

FAQ's of idarubicin injection:


Q: How should idarubicin injection be administered to patients?

A: Idarubicin injection is administered intravenously, either as an infusion or a bolus, under the supervision of qualified healthcare professionals. Dosage and infusion rates are determined according to clinical protocol and patient requirements.

Q: What are the compatible diluents for idarubicin injection?

A: For infusion, idarubicin injection is compatible with 0.9% saline or 5% dextrose solutions. The injection is provided ready-to-use, so further reconstitution is unnecessary for these presentations.

Q: When is idarubicin injection indicated?

A: Idarubicin is most commonly indicated for treating patients with acute myeloid leukemia (AML), especially those who have relapsed or are refractory to first-line treatments. It may also be used in other hematologic malignancies as directed by clinical protocols.

Q: Where should idarubicin injection be stored before use?

A: The vials should be stored below 25C (77F), protected from light, and must not be frozen. Proper storage ensures stability of the medication throughout its shelf life of 24 months (unopened).

Q: What safety precautions must be observed when handling idarubicin injection?

A: Idarubicin is classified as a cytotoxic agent, requiring personnel to wear gloves and appropriate protective equipment during preparation and administration. All waste, including vials and consumables, should be disposed of as hazardous pharmaceutical waste according to local guidelines.

Q: What are the benefits of using ready-to-use idarubicin injection vials?

A: The ready-to-use formulation eliminates the need for on-site reconstitution, minimizing the risk of dosing errors, contamination, and exposure to cytotoxic drugs, thereby streamlining administration and improving safety for both patients and healthcare staff.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Drugs' category



Back to top